WCN25-1826 Tocilizumab – A Hope for Chronic Antibody Mediated Rejection

Saved in:
Bibliographic Details
Main Authors: Abhishek Vashisth, Arpita Ray Chaudhury, Sanjana Sharma, Saugat Dasgupta, Sanjay Dasgupta, Koushik Bhattacharjee, Atanu Pal, Keya Basu, Arunansu Bandyopadhyay
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924029127
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849690419894419456
author Abhishek Vashisth
Arpita Ray Chaudhury
Sanjana Sharma
Saugat Dasgupta
Sanjay Dasgupta
Koushik Bhattacharjee
Atanu Pal
Keya Basu
Arunansu Bandyopadhyay
author_facet Abhishek Vashisth
Arpita Ray Chaudhury
Sanjana Sharma
Saugat Dasgupta
Sanjay Dasgupta
Koushik Bhattacharjee
Atanu Pal
Keya Basu
Arunansu Bandyopadhyay
author_sort Abhishek Vashisth
collection DOAJ
format Article
id doaj-art-c99e9961e7f64045bb0c60a1f5e7d92e
institution DOAJ
issn 2468-0249
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-c99e9961e7f64045bb0c60a1f5e7d92e2025-08-20T03:21:18ZengElsevierKidney International Reports2468-02492025-02-01102S49410.1016/j.ekir.2024.11.890WCN25-1826 Tocilizumab – A Hope for Chronic Antibody Mediated RejectionAbhishek Vashisth0Arpita Ray Chaudhury1Sanjana Sharma2Saugat Dasgupta3Sanjay Dasgupta4Koushik Bhattacharjee5Atanu Pal6Keya Basu7Arunansu Bandyopadhyay8Nephrology, IPGMER and SSKM, Kolkata, IndiaNephrology, NBMC, Siliguri, IndiaNephrology, IPGMER and SSKM, Kolkata, IndiaNephrology, CNMC, Kolkata, IndiaNephrology, IPGMER and SSKM, Kolkata, IndiaNephrology, IPGMER and SSKM, Kolkata, IndiaNephrology, IPGMER and SSKM, Kolkata, IndiaPathology, IPGMER and SSKM, Kolkata, IndiaNephrology, IPGMER and SSKM, Kolkata, Indiahttp://www.sciencedirect.com/science/article/pii/S2468024924029127
spellingShingle Abhishek Vashisth
Arpita Ray Chaudhury
Sanjana Sharma
Saugat Dasgupta
Sanjay Dasgupta
Koushik Bhattacharjee
Atanu Pal
Keya Basu
Arunansu Bandyopadhyay
WCN25-1826 Tocilizumab – A Hope for Chronic Antibody Mediated Rejection
Kidney International Reports
title WCN25-1826 Tocilizumab – A Hope for Chronic Antibody Mediated Rejection
title_full WCN25-1826 Tocilizumab – A Hope for Chronic Antibody Mediated Rejection
title_fullStr WCN25-1826 Tocilizumab – A Hope for Chronic Antibody Mediated Rejection
title_full_unstemmed WCN25-1826 Tocilizumab – A Hope for Chronic Antibody Mediated Rejection
title_short WCN25-1826 Tocilizumab – A Hope for Chronic Antibody Mediated Rejection
title_sort wcn25 1826 tocilizumab a hope for chronic antibody mediated rejection
url http://www.sciencedirect.com/science/article/pii/S2468024924029127
work_keys_str_mv AT abhishekvashisth wcn251826tocilizumabahopeforchronicantibodymediatedrejection
AT arpitaraychaudhury wcn251826tocilizumabahopeforchronicantibodymediatedrejection
AT sanjanasharma wcn251826tocilizumabahopeforchronicantibodymediatedrejection
AT saugatdasgupta wcn251826tocilizumabahopeforchronicantibodymediatedrejection
AT sanjaydasgupta wcn251826tocilizumabahopeforchronicantibodymediatedrejection
AT koushikbhattacharjee wcn251826tocilizumabahopeforchronicantibodymediatedrejection
AT atanupal wcn251826tocilizumabahopeforchronicantibodymediatedrejection
AT keyabasu wcn251826tocilizumabahopeforchronicantibodymediatedrejection
AT arunansubandyopadhyay wcn251826tocilizumabahopeforchronicantibodymediatedrejection